🇺🇸 FDA
Patent

US 9359598

Mutant MT-SP1 proteases with altered substrate specificity or activity

granted A61PA61P27/02A61P29/00

Quick answer

US patent 9359598 (Mutant MT-SP1 proteases with altered substrate specificity or activity) held by Catalyst Biosciences, Inc. expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Catalyst Biosciences, Inc.
Grant date
Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P27/02, A61P29/00, A61P3/10, A61P31/00